These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19751247)

  • 1. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study.
    Camilleri M; Beyens G; Kerstens R; Robinson P; Vandeplassche L
    Neurogastroenterol Motil; 2009 Dec; 21(12):1256-e117. PubMed ID: 19751247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
    Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
    Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
    Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prucalopride, a systemic enterokinetic, for the treatment of constipation.
    Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
    Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ
    Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prucalopride is no more effective than placebo for children with functional constipation.
    Mugie SM; Korczowski B; Bodi P; Green A; Kerstens R; Ausma J; Ruth M; Levine A; Benninga MA
    Gastroenterology; 2014 Dec; 147(6):1285-95.e1. PubMed ID: 25239590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
    Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A
    Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
    Coremans G; Kerstens R; De Pauw M; Stevens M
    Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation.
    Müller-Lissner S; Rykx A; Kerstens R; Vandeplassche L
    Neurogastroenterol Motil; 2010 Sep; 22(9):991-8, e255. PubMed ID: 20529205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
    Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prucalopride: a new drug for the treatment of chronic constipation.
    Tack J
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.
    Malagelada C; Nieto A; Mendez S; Accarino A; Santos J; Malagelada JR; Azpiroz F
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1457-1462. PubMed ID: 28090679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.
    Ke M; Zou D; Yuan Y; Li Y; Lin L; Hao J; Hou X; Kim HJ
    Neurogastroenterol Motil; 2012 Nov; 24(11):999-e541. PubMed ID: 22882724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prucalopride: a review of its use in the management of chronic constipation.
    Keating GM
    Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.
    Johanson JF; Wald A; Tougas G; Chey WD; Novick JS; Lembo AJ; Fordham F; Guella M; Nault B
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):796-805. PubMed ID: 15354280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.